Genzyme Articles
Callisto and Genzyme amend Atiprimod deal
14 January 2008
Isis in possible $1.5B deal with Genzyme
14 January 2008
Genzyme's Synvisc-One awarded EU CE mark
24 December 2007
FDA clears Thyrogen for use in ablation
24 December 2007
Genzyme hoping to expand Clolar into adult AML
17 December 2007
Fovea and Genzyme establish R&D accord
3 December 2007
Genzyme's Epicel OKed by FDA
5 November 2007
Strong third quarter for Genzyme: GAAP net income reaches $159M on the back of good sales
5 November 2007
Genzyme and Sunway sign PAH drug deal
5 November 2007
FDA approves Genzyme's Renvela
29 October 2007
Bioenvision stockholders approve aquisition by Genzyme
29 October 2007
CHMP advocates MabCampath approval
29 October 2007
FDA's CRDAC votes to expand P binders in CKD
29 October 2007
Stock Commentary - New York - week to October 15, 2007
22 October 2007
Stock Commentary - Europe - week to October 15, 2007
22 October 2007
Alemtuzumab cuts relapse risk in RRMS
22 October 2007
US FDA to consider phosphate binders for kidney disease
22 October 2007
Bioenvision and Genzyme file petition on merger
15 October 2007
Japan's MHLW OKs Shire's Elaprase
15 October 2007
Genzyme's Lyon plant gets FDA warning letter
8 October 2007
Stock Commentary - New York - week to Oct 1, 2007
8 October 2007
Genzyme/Bayer start Ph III alemtuzumab program
1 October 2007
FDA approves Campath as single agent for B-CLL
1 October 2007
Genzyme will not up $5.60/share offer for Bioenvision
27 September 2007
Genzyme begins $150M expansion of flagship plant
24 September 2007
Stock Commentary - New York week to Aug 13, 2007
20 August 2007
BioMarin's 2nd-qtr 2007 loss widens to $3.9M
20 August 2007
Genzyme settles law suit for $64 million
20 August 2007
Mozobil meets Ph III endpoints in NHL
13 August 2007
Genzyme's 2nd-qtr net income jumps 4%
6 August 2007
Ph III Mozobil trial meets primary endpoint
30 July 2007
Genzyme's Carticel impresses in STAR study
23 July 2007
Genzyme completes tender offer for Bioenvision
16 July 2007
Stock Commentary - New York week to July 9, 2007
16 July 2007
Genzyme's hylastan falls short in OA trial
16 July 2007
Stock Commentary - New York week to June 18, 2007
25 June 2007
Genzyme to build $141.4M plant in France
18 June 2007
Stock Commentary - New York week to June 4, 2007
11 June 2007
Strong Ph II data on Genzyme/Bayer's MS drug
14 May 2007
Genzyme's 1st-qtr net income soars 57%
7 May 2007
Genzyme/Bayer file for Campath label expansion
16 April 2007
Dyax and Genzyme end HAE accord
26 February 2007
Genzyme sees 4th-qtr loss on AnorMED buy
26 February 2007
Stock Commentary - New York week to Jan 8, 2007
15 January 2007
Lower death rate with Genzyme
15 January 2007
Genzyme to pay damages under new UK procedure
18 December 2006
CBI to buy Australia Mimotopes for stock
4 December 2006
NsGene's NsG33 protein licensed by Genzyme
4 December 2006
Biotech takeovers gather pace, reaching a record level
13 November 2006
CMS reimbursement cut for osteoarthritis challenged
6 November 2006
Genzyme extends offer for AnorMED
6 November 2006
Freedonia predicts 7% per year rise in US enzyme demand to 2010
30 October 2006
Millennium bows out of AnorMED bidding
23 October 2006
Genzyme Japan appoints general manager
23 October 2006
Genzyme, MMV and Broad Inst expand Malaria drug accord
23 October 2006
Genzyme proceeds with AnorMED buy
23 October 2006
AnorMed board backs Millennium bid
16 October 2006
New indications OKed for Genzyme's Synvisc
9 October 2006
Stock Commentary - New York week to Sept 25, 2006
2 October 2006
Biotech stocks in holding pattern for August, says Burrill report
18 September 2006
13 new drugs added to Japan's NHI list
18 September 2006
Japan stock market week to Sept 4, 2006
11 September 2006
AnorMED spurns Genzyme offer
4 September 2006
Genzyme starts dosing in Gaucher disease trial
7 August 2006
Genzyme's 2nd-qtr 2006 revenue rises 19%
24 July 2006
Stock Commentary - New York week to July 10, 2006
17 July 2006
Stock Commentary - New York week toJune 26, 2006
3 July 2006
SR Pharma in GMP manufacturing deals
26 June 2006
BTG's fiscal 2005/06 income rises 31%
5 June 2006
Stock Commentary - New York week to May 22, 2006
29 May 2006
Genzyme's gene therapy assessed in PAD
22 May 2006
US FDA approves Genzyme's Myozyme
8 May 2006
Genzyme's 1st-qtr sales less than expected
1 May 2006
Amicus' Amigal gets OD nod from COMP
24 April 2006
Genzyme's Myozyme gets EU go-ahead
10 April 2006
Genzyme confirms strong 2006 guidance
27 February 2006
Genzyme debut Gleevec resistance test
13 February 2006
Genzyme gets label change for Thyrogen
6 February 2006
Pharma/biotech mergers and acquisitions during 2005
6 February 2006
Tripos enters new partnerships
30 January 2006
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
